Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,085 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period: A Single-Center Retrospective Study.
Tanaka Y, Yamamoto K, Morimoto S, Nabeshima T, Matsushima K, Ishimoto H, Ashizawa N, Hirayama T, Takeda K, Gyotoku H, Iwanaga N, Takemoto S, Fukahori S, Takazono T, Yamaguchi H, Kido T, Sakamoto N, Hosogaya N, Akabame S, Sugimoto T, Yamanashi H, Matsui K, Izumida M, Fujita A, Tashiro M, Tanaka T, Ariyoshi K, Furumoto A, Morita K, Izumikawa K, Yanagihara K, Mukae H. Tanaka Y, et al. Among authors: morimoto s. J Clin Med. 2022 Sep 16;11(18):5444. doi: 10.3390/jcm11185444. J Clin Med. 2022. PMID: 36143099 Free PMC article.
Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study.
Hamaguchi S, Suzuki M, Sasaki K, Abe M, Wakabayashi T, Sando E, Yaegashi M, Morimoto S, Asoh N, Hamashige N, Aoshima M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group – Japan. Hamaguchi S, et al. Among authors: morimoto s, morimoto k. BMC Pulm Med. 2018 May 23;18(1):88. doi: 10.1186/s12890-018-0648-y. BMC Pulm Med. 2018. PMID: 29792181 Free PMC article.
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis.
Fukui S, Morimoto S, Ichinose K, Nakashima S, Ishimoto H, Hara A, Kakugawa T, Sakamoto N, Tsuji Y, Aramaki T, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Ueki Y, Suzuki S, Mukae H, Kawakami A. Fukui S, et al. Among authors: morimoto s. Sci Rep. 2020 Jun 11;10(1):9466. doi: 10.1038/s41598-020-66178-4. Sci Rep. 2020. PMID: 32528054 Free PMC article.
Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments.
Shimizu T, Kawashiri SY, Sato S, Morimoto S, Minoda S, Kawazoe Y, Kuroda S, Tashiro S, Sumiyoshi R, Hosogaya N, Yamamoto H, Kawakami A. Shimizu T, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Aug 7;99(32):e21480. doi: 10.1097/MD.0000000000021480. Medicine (Baltimore). 2020. PMID: 32769882 Free PMC article.
Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease: Study protocol for clinical trial.
Koga T, Hagimori N, Takemori S, Morimoto S, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Jul 24;99(30):e20710. doi: 10.1097/MD.0000000000020710. Medicine (Baltimore). 2020. PMID: 32791665 Free PMC article.
Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound, and biomarker assessments.
Kawashiri SY, Shimizu T, Sato S, Morimoto S, Kawazoe Y, Sumiyoshi R, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Kawashiri SY, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Jul 24;99(30):e21151. doi: 10.1097/MD.0000000000021151. Medicine (Baltimore). 2020. PMID: 32791688 Free PMC article.
An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant).
Koga T, Takemori S, Hagimori N, Morimoto S, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: morimoto s. Medicine (Baltimore). 2020 Dec 11;99(50):e23291. doi: 10.1097/MD.0000000000023291. Medicine (Baltimore). 2020. PMID: 33327255 Free PMC article.
2,085 results